Latest Market News

Pro Medicus has signed a seven-year, A$24 million contract with Billings Clinic - Logan Health for a cloud-based deployment of its Visage 7 imaging platform. The transaction-based structure offers potential additional upside, although the announcement does not quantify future volumes or revenue timing.

Hazer Group has expanded its commercial pipeline through a paid Japanese utility study assessing hydrogen facilities of up to 300,000 tonnes per year, while its KBR alliance advances a standardised commercial-scale design. The company ended September with A$8.3 million in cash and reported A$12.9 million in pro-forma funding, but remains pre-revenue in the quarter.

New Hope has agreed to acquire the Malabar shares it does not already own in an all-scrip deal valuing Malabar at about A$1.8 billion. The transaction would give New Hope full control of the ramping Maxwell underground mine and create a coal group targeting roughly 19Mtpa of saleable production.

Arena REIT has raised its FY2027 distribution guidance to 19.0-20.2 cents per security as rent collection and replacement operator arrangements improve across its troubled Edge portfolio. The upgrade remains partly dependent on transactions, lease assignments and approvals being completed.

Advanced Braking Technology increased Q1 FY27 product sales by 8.3% and ended September with $7.3 million in bank cash. The mining safety company also moved BRAKEiQ closer to CAS Level 9 certification, although the quarter produced a small loss before tax.

Reliance Worldwide Corporation’s go-shop period has ended without an alternative proposal, leaving Brookfield’s US$3.38-per-share takeover as the only deal before shareholders. The board has reaffirmed its unanimous recommendation, but the scheme still requires shareholder, Court, regulatory and expert approval.

McPherson’s chief executive and managing director Brett Charlton will step down after more than three years at the helm, with the board beginning an immediate search for his successor. Charlton will remain in the role during a six-month notice period, subject to arrangements agreed with the board.

Monadelphous Group Limited (ASX:MND) enters FY27 with record FY26 revenue of $2.98 billion, a 52.1% profit increase and more than $680 million of new contracts secured since year-end. The engineering services group is also carrying a disputed claim worth about $200 million and a sizeable exposure to fossil-fuel markets.

Neometals has cut its annual loss and sharpened its portfolio, but Deloitte has warned of a material uncertainty over the company’s ability to continue as a going concern. The miner says it may need about A$5 million in additional funding from December while pursuing unpaid placement proceeds from Omaha Value Holdings.

Amplia Therapeutics has told ASX it is unaware of any undisclosed information that explains a sharp fall in its share price and a surge in trading volume. The response followed an ASX price query issued after the stock dropped from $0.100 to $0.079 on 16 October.

Cleanaway has told ASX it knows of no undisclosed information behind a sharp intraday share-price fall. The company said it will provide another update on EQT’s proposed takeover before trading begins on 19 October.

Noxopharm has completed its first-in-human safety trial for SOF-SKN and advanced the wider Sofra platform, but its annual report flags a material uncertainty over funding. The biotech ended June with A$293,573 in cash, net liabilities of A$3.65 million and a need for additional capital.